FDA Commissioner Scott Gottlieb Announces He Will Resign

Milestones :: Perspectives

FDA Commissioner Scott Gottlieb Announces He Will Resign
March 5, 20194:08 PM ET
Laurel Wamsley

The commissioner of the Food and Drug Administration, Scott Gottlieb, announced Tuesday that he is resigning the position, effective in one month.

Gottlieb won approval from many as an effective advocate for public health. Within the Trump administration, he stood out for his efforts to more tightly regulate several industries; he’s been particularly intent on curbing vaping and making generic drugs more accessible.

Gottlieb is a physician who was previously the FDA’s Deputy Commissioner for Medical and Scientific Affairs. He became commissioner in May 2017. The reasons for his resignation are not yet clear, but it appears it was not requested by the White House.

President Trump tweeted his high regard for the commissioner on Tuesday afternoon, writing that he has done “an absolutely terrific job. …. Scott has helped us to lower drug prices, get a record number of generic drugs approved and onto the market, and so many other things. He and his talents will be greatly missed!”

Gottlieb tweeted in return that he was “immensely grateful for the opportunity” to lead the agency…